{"gene":"BIRC6","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2004,"finding":"BIRC6/BRUCE functions as a chimeric E2/E3 ubiquitin ligase and IAP: it inhibits caspase activity and apoptosis via its BIR domain, is antagonized by Smac binding, by HtrA2 protease cleavage, and by caspase-mediated cleavage, and ubiquitinates Smac as a substrate. BRUCE localizes to the trans-Golgi network as a peripheral membrane protein.","method":"Wild-type and mutant BRUCE constructs, Co-IP, in vitro ubiquitination assay, apoptosis assays, subcellular fractionation/localization","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (mutagenesis, in vitro ubiquitination, Co-IP, localization) in a single rigorous study; key findings replicated by independent labs","pmids":["15200957"],"is_preprint":false},{"year":2004,"finding":"BRUCE/Apollon associates with both precursor and mature forms of Smac and caspase-9 (binding regions beyond the IAP-binding motif), promotes proteasomal degradation of Smac, and inhibits caspase-9 activity but not caspase-3 activity. Upon apoptotic stimuli, BRUCE is degraded by proteasomes and/or cleaved by caspases or HtrA2 depending on stimulus and cell type.","method":"Co-immunoprecipitation, in vitro caspase activity assays, proteasome inhibitor experiments, cell-based apoptosis assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP plus functional enzymatic assays; independently consistent with Bartke et al. 2004","pmids":["15507451"],"is_preprint":false},{"year":2004,"finding":"Nrdp1/FLRF, a RING-finger E3 ubiquitin ligase, associates with BRUCE and, in the presence of exogenous E2 UbcH5c, catalyzes BRUCE ubiquitination in vitro. Nrdp1 overexpression promotes BRUCE ubiquitination and proteasomal degradation in vivo; RNAi knockdown of Nrdp1 reduces apoptosis-induced BRUCE loss. Thus Nrdp1 is a writer that targets BRUCE for degradation to promote apoptosis.","method":"Co-immunoprecipitation, in vitro ubiquitination assay with purified proteins, RNAi knockdown, proteasome inhibitor experiments","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro reconstitution with purified proteins plus cellular RNAi confirmation; replicated in subsequent studies","pmids":["14765125"],"is_preprint":false},{"year":2005,"finding":"Deletion of the C-terminal half of BRUCE (including the UBC domain) in mice activates caspases and apoptosis in placenta/yolk sac causing embryonic lethality, associated with p53 nuclear localization, upregulation of Bax, Bak, Pidd, mitochondrial translocation of Bax and caspase-2, cytochrome c and AIF release, and caspase-9/-3 activation. p53 RNAi rescue in human H460 cells confirms p53 is a downstream effector of BRUCE in the mitochondrial apoptosis pathway.","method":"Conditional knockout mouse, RNAi rescue in cell lines, Western blot, immunofluorescence, caspase activity assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic knockout plus orthogonal RNAi rescue with mechanistic pathway dissection","pmids":["15640352"],"is_preprint":false},{"year":2004,"finding":"BRUCE-deficient mice die perinatally with growth retardation linked to impaired placental labyrinth maturation and spongiotrophoblast reduction; no elevated apoptosis was detected in knockout tissues or fibroblasts, suggesting a role in placental/trophoblast differentiation distinct from anti-apoptotic function.","method":"Gene targeting/knockout mouse, histology, TUNEL apoptosis assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockout with defined cellular phenotype; independently replicated by Hitz et al. 2005 and Ren et al. 2005","pmids":["15485903"],"is_preprint":false},{"year":2008,"finding":"BRUCE is a major regulator of cytokinesis abscission: during cytokinesis it relocates from vesicular/trans-Golgi network compartments to the midbody ring, serving as a platform for membrane delivery machinery and mitotic regulators. BRUCE depletion causes defective abscission, cytokinesis-associated apoptosis, blocked vesicular targeting, and defective midbody ring formation. Ubiquitin relocalizes from midbody microtubules to the midbody ring during cytokinesis, and BRUCE depletion disrupts this ubiquitin relocalization.","method":"RNAi depletion in cell culture, live-cell imaging, immunofluorescence, electron microscopy, co-localization studies","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean RNAi with defined cellular phenotype, multiple imaging modalities, mechanistic dissection of ubiquitin dynamics","pmids":["18329369"],"is_preprint":false},{"year":2015,"finding":"BRUCE acts as a scaffold bridging USP8 and BRIT1 in a nuclear complex; it promotes USP8-catalyzed deubiquitination of K63-ubiquitinated BRIT1, which is a prerequisite for BRIT1 recruitment to DNA double-strand breaks (DSBs) via γ-H2AX. Loss of BRUCE impairs BRIT1 deubiquitination, BRIT1-γH2AX binding, BRIT1 DSB foci, chromatin relaxation, and homologous recombination repair. BRUCE-mutant mice show genomic instability.","method":"Co-immunoprecipitation, in vitro deubiquitination assay, RNAi knockdown, immunofluorescence foci assays, HR repair assay, mouse genetics","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — biochemical complex reconstitution by Co-IP, functional HR assay, in vivo mouse model, multiple orthogonal methods","pmids":["25733871"],"is_preprint":false},{"year":2015,"finding":"The UBC (E2) domain of BRUCE, but not its BIR domain, is required for BRIT1 deubiquitination and recruitment to DSBs: UBC domain mutation or deletion does not disrupt the BRUCE-USP8-BRIT1 complex but impairs downstream deubiquitination and DSB repair, implicating BRUCE's E3 ligase activity in facilitating USP8-mediated deubiquitination.","method":"Domain deletion/point mutation analysis, Co-IP, γ-H2AX/BRIT1 foci assays, HR repair assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single lab, but multiple orthogonal assays with domain mutants supporting mechanistic conclusion","pmids":["26683461"],"is_preprint":false},{"year":2018,"finding":"BIRC6/BRUCE positively regulates autophagosome-lysosome fusion: BRUCE depletion leads to defective autophagosome-lysosome fusion. BRUCE selectively interacts with ATG8 family members GABARAP and GABARAPL1, and with Syntaxin 17 (STX17), all critical regulators of autophagosome-lysosome fusion. BRUCE co-localizes with LAMP2 (lysosomal marker). A non-catalytic N-terminal fragment lacking the UBC domain rescues autolysosome formation in Bruce-/- cells, indicating this role is independent of ubiquitin-conjugating activity.","method":"RNAi screen, Co-immunoprecipitation, autophagy flux assays (tandem fluorescent LC3), immunofluorescence co-localization, domain deletion rescue experiments","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, functional rescue with domain mutant, multiple orthogonal autophagy assays; independently replicated by Ikeda 2018 commentary and other groups","pmids":["29426817"],"is_preprint":false},{"year":2019,"finding":"UBA6 and BIRC6 cooperate to monoubiquitinate LC3B, targeting it for proteasomal degradation, thereby negatively regulating autophagy. Knockout of UBA6 or BIRC6 increases autophagic flux under nutrient deprivation or protein synthesis inhibition, decreases aggresome-like structures and α-synuclein aggregates.","method":"Whole-genome CRISPR/Cas9 knockout screen, genetic rescue, autophagic flux assays (tandem GFP-mCherry-LC3B), immunoprecipitation, proteasome inhibitor experiments","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — unbiased CRISPR screen followed by mechanistic validation with multiple orthogonal assays; UBA6-BIRC6 E1-E2 pairing confirmed biochemically","pmids":["31692446"],"is_preprint":false},{"year":2019,"finding":"BRUCE together with proteasome activator PA28γ promotes proteasomal degradation of LC3-I, inhibiting autophagy initiation. SIP/CacyBP inhibits Nrdp1-mediated ubiquitination of BRUCE under normal conditions, thereby protecting BRUCE. Upon starvation, SIP together with Rab8 promotes translocation of BRUCE into recycling endosomes and autophagic degradation of BRUCE by optineurin-mediated autophagy, thus relieving BRUCE-dependent LC3-I degradation.","method":"Co-immunoprecipitation, in vitro ubiquitination assay, autophagy flux assays, confocal microscopy, RNAi knockdown, cell fractionation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Co-IP, biochemical assays, live imaging) in a single mechanistic study","pmids":["31213539"],"is_preprint":false},{"year":2019,"finding":"BRUCE is required for ATR activation during replication stress: BRUCE is recruited to DNA damage sites, and BRUCE depletion impairs ATR activation, phosphorylation of CHK1 and RPA, and monoubiquitination of FANCD2, resulting in stalled replication forks and increased replication origin firing. Liver-specific Bruce knockout in mice impairs ATR activation and promotes hepatocellular carcinoma development.","method":"RNAi depletion, immunofluorescence, Western blot for ATR-pathway markers, DNA fiber assay, liver-specific conditional knockout mouse, diethylnitrosamine carcinogenesis model","journal":"Hepatology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vitro mechanistic evidence plus in vivo genetic validation with multiple pathway readouts","pmids":["30693543"],"is_preprint":false},{"year":2019,"finding":"BRUCE depletion lowers cellular ATP/AMP ratio, activating AMPK (pThr-172) and downstream ULK1 (pSer-555), which induces autophagy independently of starvation. This energy-sensing pathway establishes a BRUCE-AMPK-ULK1 axis in autophagy regulation.","method":"RNAi knockdown, AMP/ATP ratio measurement, Western blot for AMPK and ULK1 phosphorylation, LC3 puncta quantification, autophagy flux assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single lab, multiple biochemical readouts supporting AMPK-ULK1 axis but no direct BRUCE-AMPK interaction demonstrated","pmids":["31091257"],"is_preprint":false},{"year":2011,"finding":"Drosophila BRUCE (dBruce) physically interacts with the IAP-antagonist Reaper via Reaper's IBM and GH3 motifs and promotes Reaper ubiquitination on unconventional non-lysine acceptor sites (as demonstrated with lysine-deficient Reaper mutants). Loss of dBruce elevates Reaper protein levels, indicating BRUCE inhibits apoptosis by targeting IAP-antagonists for ubiquitination.","method":"Co-immunoprecipitation, in vitro ubiquitination assay with lysine-deficient substrates, genetic loss-of-function (dBruce-/- background), RNAi knockdown","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — biochemical reconstitution of ubiquitination on defined substrate mutants plus genetic validation","pmids":["21886178"],"is_preprint":false},{"year":2008,"finding":"Prostaglandin F2alpha (PGF2alpha) increases BRUCE expression in skeletal myoblasts via the NFAT2 transcription factor pathway, and PGF2alpha-mediated reduction of muscle cell death during myogenesis is dependent on BRUCE. Overexpression of BRUCE alone is sufficient to promote muscle cell survival and myotube growth.","method":"In vitro myogenesis, siRNA knockdown, BRUCE overexpression, NFAT2 inhibitor experiments, in vivo muscle injury model","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — single lab, multiple assays (KD, OE, in vivo) but NFAT2-BRUCE transcriptional link not directly shown by promoter assay","pmids":["18566603"],"is_preprint":false},{"year":2023,"finding":"Cryo-EM structures of full-length human BIRC6 reveal it forms an antiparallel homodimer arranged in a megadalton crescent shape with a central cavity containing receptor sites for client proteins (caspase-9, HTRA2, SMAC, LC3B). BIRC6 directly restricts executioner caspases-3 and -7, ubiquitinates caspases-3, -7, and -9 exclusively via the noncanonical E1 UBA6. SMAC binds BIRC6 at multiple sites with subnanomolar affinity, competitively displacing caspases and thus antagonizing BIRC6 anti-caspase function. SMAC binding to BIRC6 obstructs client binding, impeding ubiquitination of both apoptotic and autophagic substrates.","method":"Cryo-electron microscopy structure determination, in vitro ubiquitination assays, binding competition assays, structure-function mutagenesis","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 / Strong — three independent cryo-EM structural studies in the same issue, with functional validation by in vitro assays; orthogonal studies (PMIDs 36758104, 36758105, 36758106) provide convergent structural and biochemical evidence","pmids":["36758105","36758104","36758106"],"is_preprint":false},{"year":2024,"finding":"BIRC6 forms an anti-parallel U-shaped dimer with multiple previously unannotated domains including a ubiquitin-like domain. Smac/DIABLO outcompetes effector caspase-3 and HtrA2 but not procaspase-9 for binding to the BIRC6 central cavity. BIRC6 binds LC3 through an LC3-interacting region (LIR), and mutation of the LC3 ubiquitylation site promotes autophagy and autophagic degradation of BIRC6. Induction of autophagy promotes autophagic degradation of BIRC6 and caspase-9 but not other effector caspases.","method":"Cryo-EM structure, in vitro binding competition assays, site-directed mutagenesis, autophagy flux assays, Co-immunoprecipitation","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cryo-EM plus functional mutagenesis and binding assays in single study; consistent with independent structural studies","pmids":["38291026"],"is_preprint":false},{"year":2025,"finding":"BIRC6 is a UBA6-exclusive E2 enzyme that gains priority over all other UBA6-competent E2s through an exceptionally high-affinity interaction driven by BIRC6 engagement with the UBA6 ubiquitin fold domain (modulated by the UBA6 Cys-Cap loop). BIRC6 uses a bespoke thioester switch mechanism to disengage from UBA6 upon receiving ubiquitin, preventing UBA6 inhibition. This E1-E2 priority underpins BIRC6's functional importance in regulating cell death, embryogenesis, and autophagy.","method":"Structural capture of BIRC6-UBA6 complex in multiple states (cryo-EM/crystallography), in vitro ubiquitin transfer assays, mutagenesis of UBA6 Cys-Cap loop, E2 competition assays","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — structural determination with functional reconstitution and mutagenesis in a single rigorous study","pmids":["41350950"],"is_preprint":false},{"year":2014,"finding":"BIRC6 interacts with p53 and facilitates its ubiquitin-proteasome-mediated degradation in hepatocellular carcinoma cells. BIRC6 knockdown stabilizes p53, and RNA interference targeting p53 partially reverses the pro-apoptotic effects of BIRC6 depletion.","method":"Co-immunoprecipitation, Western blot, siRNA knockdown, lentiviral shRNA, in vivo xenograft","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP plus functional RNAi rescue; single lab, no in vitro ubiquitination reconstitution","pmids":["25196217"],"is_preprint":false},{"year":2017,"finding":"BIRC6 stability is regulated by the Src-family kinase Lyn: RNAi knockdown or pharmacological inhibition of Lyn reduces BIRC6 protein stability and increases formation of an N-terminal BIRC6 cleavage fragment, coinciding with reduced BIRC6 phosphopeptide (S480/S482/S486), suggesting Lyn-dependent phosphorylation stabilizes BIRC6.","method":"Phosphoproteomic mass spectrometry, RNAi knockdown, kinase inhibitors (dasatinib/ponatinib), Western blot","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — phosphoproteomics identification plus functional knockdown validation; single lab, no direct in vitro kinase assay","pmids":["28520795"],"is_preprint":false},{"year":2021,"finding":"BIRC6 stability is increased by EGF-JNK signaling, which prevents BIRC6 ubiquitination and degradation mediated by the E3 ubiquitin ligase HECTD1. BIRC6 in turn decreases SMAC expression by inducing the ubiquitin-proteasome pathway in TNBC cells.","method":"Co-immunoprecipitation, Western blot, siRNA knockdown, EGF/JNK pathway inhibitors, in vivo xenograft","journal":"Molecular therapy. Nucleic acids","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP and pathway inhibitor evidence in a single lab; HECTD1-BIRC6 direct ubiquitination not reconstituted in vitro","pmids":["34729249"],"is_preprint":false},{"year":2021,"finding":"In hepatocytes, BRUCE co-localizes and interacts with PKA in the cytoplasm, suppressing PKA activity and thereby reducing PKA-dependent phosphorylation (Ser-675) and nuclear accumulation of β-catenin. BRUCE deficiency elevates PKA activity and pSer-675-β-catenin, establishing a BRUCE-PKA-β-catenin signaling axis in liver disease progression.","method":"Liver-specific conditional knockout mouse, Co-immunoprecipitation, kinase activity assay, Western blot, immunofluorescence","journal":"World journal of hepatology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — in vivo genetic model plus biochemical Co-IP; direct BRUCE-PKA interaction not reconstituted in vitro","pmids":["33815677"],"is_preprint":false},{"year":2024,"finding":"BIRC6 interacts with KRAS4A (but not KRAS4B) on the Golgi apparatus and mono- and di-ubiquitinates KRAS4A at lysines 128 and 147. BIRC6 silencing diminishes GTP loading of KRAS4A and growth stimulation by KRAS4A but not KRAS4B.","method":"Proximity labeling (BioID), Co-immunoprecipitation, in vitro ubiquitination assay, mass spectrometry identification of ubiquitination sites, RNAi knockdown, GTP-loading assay","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — proximity labeling plus biochemical Co-IP and in vitro ubiquitination with site identification; single lab but multiple orthogonal methods","pmids":["39705142"],"is_preprint":false},{"year":2020,"finding":"In Bruce-/- male germline (conditional knockout), spermatogonia maintenance is impaired and meiotic spermatocytes show persistent DNA breaks, defective homologous synapsis, non-homologous chromosomal associations, and absent ATM/ATR signaling at unsynapsed regions, establishing BRUCE as essential for meiotic homologous recombination and genomic stability in the male germline.","method":"Conditional germline-specific knockout mouse, immunofluorescence with synapsis markers (SYCP1/3), γ-H2AX/RAD51 foci, ATM/ATR staining, chromosome spread analysis","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean conditional knockout with defined meiotic phenotype and multiple molecular markers","pmids":["32139899"],"is_preprint":false},{"year":2002,"finding":"Drosophila BRUCE (dBruce) inhibits cell death induced by Reaper and Grim but not Hid using gain-of-function and loss-of-function alleles. The BIR domain alone is insufficient; the E2 domain is required. dBruce does not promote direct degradation of Rpr or Grim, but its activity requires their N-terminal IAP-binding motifs. dBruce does not block Dronc caspase or Debcl/dBorg.","method":"Drosophila gain-of-function transgenes, loss-of-function deletion alleles, genetic epistasis, in vivo cell death assays","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic epistasis with multiple alleles and substrate specificity mapping in vivo","pmids":["12121627"],"is_preprint":false},{"year":2012,"finding":"BIRC6 binds and degrades the cytoplasmic fraction of the pro-apoptotic protein DIABLO/Smac in neuroblastoma cells: BIRC6 silencing by shRNA increases DIABLO protein levels and induces apoptosis; Co-immunoprecipitation confirmed direct BIRC6-DIABLO interaction.","method":"Lentiviral shRNA knockdown, Co-immunoprecipitation, immunofluorescence, MTT apoptosis assay","journal":"BMC cancer","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single Co-IP plus functional knockdown; consistent with in vitro biochemical data from other studies","pmids":["22788920"],"is_preprint":false},{"year":2008,"finding":"Drosophila Bruce and the effector caspase Dcp-1 regulate starvation-induced autophagy during oogenesis in two nutrient checkpoints (germarium and mid-oogenesis), demonstrating that Bruce functions at the intersection of autophagy and apoptosis regulation in vivo.","method":"Systematic RNAi screen of cell death genes, genetic loss-of-function alleles, autophagy marker assays (ATG mutants), DNA fragmentation assay, oogenesis in vivo model","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — genetic screen with in vivo validation; mechanistic link between Bruce and autophagy molecular machinery not fully defined in this study alone","pmids":["18794330"],"is_preprint":false},{"year":2009,"finding":"Dexamethasone (acting via glucocorticoid receptor) decreases BRUCE expression in neural progenitor cells (NPCs) and reduces NPC proliferation; BRUCE overexpression counteracts dexamethasone-induced reduction. Dex also elevates Usp8/Ubpy which via Nrdp1 decreases BRUCE, suggesting a glucocorticoid-Nrdp1-BRUCE axis regulating NPC cell division.","method":"Glucocorticoid receptor antagonist (RU486), RNAi silencing, BRUCE overexpression, cell proliferation assay","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single lab, KD/OE with phenotypic readout; pathway placement partly inferred","pmids":["19527720"],"is_preprint":false},{"year":2080,"finding":"BIRC6 modulates Axin protein stability via ubiquitination: BIRC6 interacts with Axin by co-immunoprecipitation, co-localizes with Axin in the cytoplasm, overexpression promotes Axin ubiquitination and degradation, and knockdown suppresses Axin ubiquitination, leading to β-catenin pathway activation in renal cancer cells.","method":"Co-immunoprecipitation, immunofluorescence co-localization, ubiquitination assay, siRNA knockdown, lentiviral overexpression, Western blot, in vivo xenograft with Wnt inhibitor","journal":"ACS omega","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP plus functional overexpression/knockdown; no in vitro reconstitution of direct ubiquitination; single lab","pmids":["38405482"],"is_preprint":false}],"current_model":"BIRC6 (BRUCE/Apollon) is a ~528 kDa peripheral membrane protein of the trans-Golgi network that functions as both a BIR domain-containing inhibitor of apoptosis (IAP) and a chimeric E2/E3 ubiquitin ligase working exclusively with the noncanonical E1 enzyme UBA6; cryo-EM structures reveal it forms an antiparallel homodimer with a central cavity that binds and ubiquitinates pro-apoptotic clients (caspases-3, -7, -9, SMAC, HtrA2) and autophagic substrate LC3, while SMAC binding at multiple sites with subnanomolar affinity competitively displaces caspases to release apoptosis; beyond apoptosis regulation, BIRC6 promotes cytokinesis abscission by relocating to the midbody ring, facilitates DNA double-strand break repair by scaffolding USP8-mediated deubiquitination of BRIT1 and activating ATR signaling at stalled replication forks, regulates autophagosome-lysosome fusion by interacting with GABARAP/GABARAPL1 and Syntaxin 17 independently of its ubiquitin-conjugating activity, and is itself subject to regulated degradation by Nrdp1-mediated ubiquitination and by autophagic clearance."},"narrative":{"mechanistic_narrative":"BIRC6 (BRUCE/Apollon) is a megadalton, trans-Golgi-associated protein that integrates apoptosis control, ubiquitin signaling, and autophagy through a single chimeric architecture combining a BIR domain with a ubiquitin-conjugating (UBC/E2) module [PMID:15200957, PMID:15507451]. As an inhibitor of apoptosis, it binds pro-apoptotic clients including caspase-9, SMAC/DIABLO, and HtrA2, restrains caspase activity, and targets clients such as SMAC for proteasomal degradation, with apoptotic signals in turn dismantling BIRC6 via caspase/HtrA2 cleavage and proteasomal turnover [PMID:15200957, PMID:15507451, PMID:22788920]. Cryo-EM structures resolve BIRC6 as an antiparallel U-shaped homodimer enclosing a central cavity that houses receptor sites for caspase-9, HtrA2, SMAC, and LC3B; it directly restricts executioner caspases-3/-7 and ubiquitinates caspases-3/-7/-9 exclusively through the noncanonical E1 UBA6, while SMAC binds at multiple subnanomolar sites to competitively displace clients and relieve their inhibition [PMID:36758105, PMID:36758104, PMID:36758106, PMID:38291026]. BIRC6 is a UBA6-exclusive E2 that wins priority over other UBA6-competent E2 enzymes via a high-affinity interaction with the UBA6 ubiquitin-fold domain and a thioester-switch mechanism that disengages it upon ubiquitin loading [PMID:41350950]. Beyond apoptosis, BIRC6 governs cytokinetic abscission by relocating from Golgi/vesicular compartments to the midbody ring [PMID:18329369], supports DNA double-strand break repair by scaffolding USP8-mediated deubiquitination of BRIT1 and activating ATR signaling at stalled forks [PMID:25733871, PMID:26683461, PMID:30693543], and is required for meiotic homologous recombination in the male germline [PMID:32139899]. It bidirectionally regulates autophagy: it promotes autophagosome-lysosome fusion through ubiquitin-independent interactions with GABARAP/GABARAPL1 and Syntaxin 17 [PMID:29426817], yet with UBA6 monoubiquitinates LC3B to drive its proteasomal degradation and negatively regulate autophagy [PMID:31692446, PMID:38291026]. BIRC6 abundance is itself tightly controlled by Nrdp1-mediated ubiquitination and by autophagic clearance [PMID:14765125, PMID:31213539]. Genetically, loss of BIRC6 function causes embryonic/perinatal lethality with placental defects in mice [PMID:15640352, PMID:15485903], and liver-specific deletion impairs ATR activation and promotes hepatocellular carcinoma [PMID:30693543].","teleology":[{"year":2004,"claim":"Established the core dual identity of BIRC6 as both an IAP and a ubiquitin ligase, answering what kind of molecule BRUCE is and how it suppresses cell death.","evidence":"Wild-type/mutant constructs, in vitro ubiquitination, Co-IP, apoptosis assays, and subcellular fractionation defining BIR-dependent caspase inhibition, Smac/HtrA2/caspase antagonism, and trans-Golgi localization","pmids":["15200957","15507451"],"confidence":"High","gaps":["Did not resolve which caspases are inhibited directly versus via ubiquitination","E1 enzyme partner not identified at this stage"]},{"year":2004,"claim":"Identified how BIRC6 levels are set, showing the RING E3 Nrdp1 ubiquitinates BRUCE for proteasomal degradation to license apoptosis.","evidence":"Co-IP, in vitro ubiquitination with purified proteins and UbcH5c, RNAi knockdown, and proteasome inhibition","pmids":["14765125"],"confidence":"High","gaps":["Did not define stimuli triggering Nrdp1 engagement","Ubiquitin chain linkage on BRUCE not characterized"]},{"year":2005,"claim":"Defined the in vivo developmental requirement and downstream apoptotic pathway, showing C-terminal/UBC-domain loss triggers p53-dependent mitochondrial apoptosis and embryonic lethality.","evidence":"Conditional knockout mouse plus p53 RNAi rescue in H460 cells with caspase and mitochondrial readouts","pmids":["15640352","15485903"],"confidence":"High","gaps":["Apparent discrepancy between apoptosis-driven lethality and apoptosis-independent placental differentiation defect not reconciled","Direct p53 ubiquitination by BIRC6 not shown here"]},{"year":2008,"claim":"Extended BIRC6 function beyond apoptosis to cell division, showing it relocates to the midbody ring to drive cytokinetic abscission and ubiquitin redistribution.","evidence":"RNAi depletion, live-cell imaging, immunofluorescence, and electron microscopy","pmids":["18329369"],"confidence":"High","gaps":["Ubiquitination substrates at the midbody ring not identified","Whether E2/E3 activity is required for abscission not resolved"]},{"year":2015,"claim":"Revealed a nuclear DNA-repair scaffold role, showing BIRC6 bridges USP8 and BRIT1 to enable BRIT1 deubiquitination and DSB recruitment via its UBC domain.","evidence":"Co-IP complex reconstitution, in vitro deubiquitination, HR repair assay, foci imaging, domain mutants, and mouse genetics","pmids":["25733871","26683461"],"confidence":"High","gaps":["How an E2/E3 domain promotes a deubiquitination reaction mechanistically remains unclear","Direct enzymatic substrate of BIRC6 in this complex not defined"]},{"year":2018,"claim":"Showed a ubiquitin-independent autophagy function, with BIRC6 promoting autophagosome-lysosome fusion via GABARAP/GABARAPL1 and STX17 interactions.","evidence":"RNAi screen, reciprocal Co-IP, tandem-fluorescent LC3 flux assays, LAMP2 co-localization, and non-catalytic N-terminal rescue","pmids":["29426817"],"confidence":"High","gaps":["Structural basis of STX17/GABARAP binding not defined here","Reconciliation with later negative regulation of autophagy not addressed"]},{"year":2019,"claim":"Defined an opposing, catalytic autophagy-suppressing role, showing UBA6-BIRC6 monoubiquitinates LC3B for degradation and that BIRC6 also acts through PA28γ, AMPK-ULK1 energy sensing, and ATR activation.","evidence":"Whole-genome CRISPR screen, IP, flux assays, AMP/ATP measurements, DNA fiber assays, and liver-specific knockout carcinogenesis model","pmids":["31692446","31213539","31091257","30693543"],"confidence":"High","gaps":["How the pro-fusion and anti-LC3 functions are balanced in cells is unresolved","No direct BIRC6-AMPK interaction demonstrated"]},{"year":2023,"claim":"Provided the structural mechanism, resolving BIRC6 as an antiparallel homodimer whose central cavity houses client receptor sites and showing SMAC competitively displaces caspases at subnanomolar affinity.","evidence":"Three convergent cryo-EM studies with in vitro ubiquitination and binding competition assays","pmids":["36758105","36758104","36758106"],"confidence":"High","gaps":["In vivo regulation of cavity occupancy not addressed","Dynamics of client exchange in cells not measured"]},{"year":2024,"claim":"Refined the structural model and substrate logic, identifying a ubiquitin-like domain and an LC3-interacting region, and showing differential SMAC competition and autophagic degradation of BIRC6 and caspase-9.","evidence":"Cryo-EM, binding competition, site-directed mutagenesis of the LC3 ubiquitylation site, and autophagy flux assays","pmids":["38291026"],"confidence":"High","gaps":["Physiological trigger for switching between LC3 ubiquitination and BIRC6 autophagic clearance not defined"]},{"year":2024,"claim":"Expanded the substrate repertoire beyond apoptosis, showing BIRC6 selectively ubiquitinates KRAS4A at the Golgi to support its GTP loading and growth signaling.","evidence":"BioID proximity labeling, Co-IP, in vitro ubiquitination with site mapping, RNAi, and GTP-loading assay","pmids":["39705142"],"confidence":"High","gaps":["Whether KRAS4A ubiquitination is UBA6-dependent not stated","Generality across cell types not established"]},{"year":2025,"claim":"Explained how BIRC6 monopolizes ubiquitin charging, demonstrating it is a UBA6-exclusive E2 that outcompetes rival E2s and uses a thioester switch to avoid inhibiting the E1.","evidence":"Multi-state structural capture of the BIRC6-UBA6 complex, ubiquitin transfer assays, UBA6 Cys-Cap loop mutagenesis, and E2 competition assays","pmids":["41350950"],"confidence":"High","gaps":["How E1-E2 priority is regulated across cellular states not addressed","Consequences for non-apoptotic substrates not tested"]},{"year":null,"claim":"How BIRC6's competing roles—anti-apoptotic IAP, bidirectional autophagy regulator, cytokinesis and DNA-repair scaffold, and KRAS4A/Axin/p53 ubiquitin ligase—are coordinated and prioritized within a single cell remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No unified model integrating ubiquitin-dependent and ubiquitin-independent functions","Tissue- and stimulus-specific substrate selection mechanisms undefined","Several cancer-context substrates (Axin, p53, HECTD1 regulation) lack in vitro reconstitution"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,9,15,22]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[0,15,17]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,15,16]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[6,8]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0,5,22]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[21,25]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[8]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,1,3,15]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[8,9,10,16]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[5]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[6,7,11,23]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[2,17]}],"complexes":[],"partners":["UBA6","SMAC/DIABLO","CASPASE-9","USP8","BRIT1","STX17","GABARAP","NRDP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NR09","full_name":"Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6","aliases":["BIR repeat-containing ubiquitin-conjugating enzyme","BRUCE","Baculoviral IAP repeat-containing protein 6","Ubiquitin-conjugating BIR domain enzyme apollon","APOLLON"],"length_aa":4857,"mass_kda":530.3,"function":"Anti-apoptotic protein known as inhibitor of apoptosis (IAP) which can regulate cell death by controlling caspases and by acting as an E3 ubiquitin-protein ligase (PubMed:14765125, PubMed:15200957, PubMed:18329369). Unlike most IAPs, does not contain a RING domain and it is not a RING-type E3 ligase (PubMed:15200957, PubMed:36758104, PubMed:36758105, PubMed:36758106). Instead acts as a dual E2/E3 enzyme that combines ubiquitin conjugating (E2) and ubiquitin ligase (E3) activities in a single polypeptide (PubMed:15200957, PubMed:36758104, PubMed:36758105, PubMed:36758106). Ubiquitination is mediated by a non-canonical E1 ubiquitin activating enzyme UBA6 (PubMed:36758104, PubMed:36758105, PubMed:36758106). Ubiquitinates CASP3, CASP7 and CASP9 and inhibits their caspase activity; also ubiquitinates their procaspases but to a weaker extent (PubMed:15200957, PubMed:36758104, PubMed:36758105, PubMed:36758106). Ubiquitinates pro-apoptotic factors DIABLO/SMAC and HTRA2 (PubMed:15200957, PubMed:36758104, PubMed:36758105, PubMed:36758106). DIABLO/SMAC antagonizes the caspase inhibition activity of BIRC6 by competing for the same binding sites as the caspases (PubMed:18329369, PubMed:36758106). Ubiquitinates the autophagy protein MAP1LC3B; this activity is also inhibited by DIABLO/SMAC (PubMed:36758105). Important regulator for the final stages of cytokinesis (PubMed:18329369). Crucial for normal vesicle targeting to the site of abscission, but also for the integrity of the midbody and the midbody ring, and its striking ubiquitin modification (PubMed:18329369)","subcellular_location":"Golgi apparatus, trans-Golgi network membrane; Endosome; Cytoplasm, cytoskeleton, spindle pole; Cytoplasm, cytoskeleton, microtubule organizing center, centrosome; Midbody, Midbody ring","url":"https://www.uniprot.org/uniprotkb/Q9NR09/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BIRC6","classification":"Not Classified","n_dependent_lines":392,"n_total_lines":1208,"dependency_fraction":0.32450331125827814},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"COPB2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/BIRC6","total_profiled":1310},"omim":[{"mim_id":"616473","title":"MICRO RNA 558; MIR558","url":"https://www.omim.org/entry/616473"},{"mim_id":"607366","title":"POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 12; KCNK12","url":"https://www.omim.org/entry/607366"},{"mim_id":"605737","title":"BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7; BIRC7","url":"https://www.omim.org/entry/605737"},{"mim_id":"605638","title":"BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 6; BIRC6","url":"https://www.omim.org/entry/605638"},{"mim_id":"600355","title":"NEURONAL APOPTOSIS INHIBITORY PROTEIN; NAIP","url":"https://www.omim.org/entry/600355"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Golgi apparatus","reliability":"Supported"},{"location":"Vesicles","reliability":"Supported"},{"location":"Mitotic spindle","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/BIRC6"},"hgnc":{"alias_symbol":["BRUCE"],"prev_symbol":[]},"alphafold":{"accession":"Q9NR09","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NR09","model_url":"","pae_url":"","plddt_mean":null},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BIRC6","jax_strain_url":"https://www.jax.org/strain/search?query=BIRC6"},"sequence":{"accession":"Q9NR09","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NR09.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NR09/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NR09"}},"corpus_meta":[{"pmid":"10606224","id":"PMC_10606224","title":"The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.","date":"1999","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10606224","citation_count":529,"is_preprint":false},{"pmid":"7850785","id":"PMC_7850785","title":"Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture.","date":"1995","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/7850785","citation_count":282,"is_preprint":false},{"pmid":"15200957","id":"PMC_15200957","title":"Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin ligase.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15200957","citation_count":183,"is_preprint":false},{"pmid":"18794330","id":"PMC_18794330","title":"Effector caspase Dcp-1 and IAP protein Bruce regulate starvation-induced autophagy during Drosophila melanogaster oogenesis.","date":"2008","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18794330","citation_count":157,"is_preprint":false},{"pmid":"18329369","id":"PMC_18329369","title":"Final stages of cytokinesis and midbody ring formation are controlled by BRUCE.","date":"2008","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/18329369","citation_count":150,"is_preprint":false},{"pmid":"15640352","id":"PMC_15640352","title":"The Birc6 (Bruce) gene regulates p53 and the mitochondrial pathway of apoptosis and is essential for mouse embryonic development.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15640352","citation_count":129,"is_preprint":false},{"pmid":"14765125","id":"PMC_14765125","title":"Nrdp1-mediated degradation of the gigantic IAP, BRUCE, is a novel pathway for triggering apoptosis.","date":"2004","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/14765125","citation_count":120,"is_preprint":false},{"pmid":"8971150","id":"PMC_8971150","title":"Beyond DNA cross-linking: history and prospects of DNA-targeted cancer treatment--fifteenth Bruce F. Cain Memorial Award Lecture.","date":"1996","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8971150","citation_count":98,"is_preprint":false},{"pmid":"23678170","id":"PMC_23678170","title":"Epstein-Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE.","date":"2013","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/23678170","citation_count":97,"is_preprint":false},{"pmid":"32019552","id":"PMC_32019552","title":"Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE.","date":"2020","source":"Journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/32019552","citation_count":86,"is_preprint":false},{"pmid":"31692446","id":"PMC_31692446","title":"Negative regulation of autophagy by UBA6-BIRC6-mediated ubiquitination of LC3.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/31692446","citation_count":85,"is_preprint":false},{"pmid":"29426817","id":"PMC_29426817","title":"The IAP family member BRUCE regulates autophagosome-lysosome fusion.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29426817","citation_count":85,"is_preprint":false},{"pmid":"21788403","id":"PMC_21788403","title":"Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target.","date":"2011","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/21788403","citation_count":78,"is_preprint":false},{"pmid":"15507451","id":"PMC_15507451","title":"The membrane-associated inhibitor of apoptosis protein, BRUCE/Apollon, antagonizes both the precursor and mature forms of Smac and caspase-9.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15507451","citation_count":78,"is_preprint":false},{"pmid":"12121627","id":"PMC_12121627","title":"Drosophila Bruce can potently suppress Rpr- and Grim-dependent but not Hid-dependent cell death.","date":"2002","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/12121627","citation_count":71,"is_preprint":false},{"pmid":"19051297","id":"PMC_19051297","title":"Die hard: are cancer stem cells the Bruce Willises of tumor biology?","date":"2009","source":"Cytometry. Part A : the journal of the International Society for Analytical Cytology","url":"https://pubmed.ncbi.nlm.nih.gov/19051297","citation_count":69,"is_preprint":false},{"pmid":"15485903","id":"PMC_15485903","title":"BRUCE, a giant E2/E3 ubiquitin ligase and inhibitor of apoptosis protein of the trans-Golgi network, is required for normal placenta development and mouse survival.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15485903","citation_count":61,"is_preprint":false},{"pmid":"17947352","id":"PMC_17947352","title":"Inactivation of the oxytocin and the vasopressin (Avp) 1b receptor genes, but not the Avp 1a receptor gene, differentially impairs the Bruce effect in laboratory mice (Mus musculus).","date":"2007","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17947352","citation_count":56,"is_preprint":false},{"pmid":"30931701","id":"PMC_30931701","title":"circ-BIRC6, a circular RNA, promotes hepatocellular carcinoma progression by targeting the miR-3918/Bcl2 axis.","date":"2019","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/30931701","citation_count":54,"is_preprint":false},{"pmid":"36758105","id":"PMC_36758105","title":"Structural basis for regulation of apoptosis and autophagy by the BIRC6/SMAC complex.","date":"2023","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/36758105","citation_count":52,"is_preprint":false},{"pmid":"31213539","id":"PMC_31213539","title":"SIP/CacyBP promotes autophagy by regulating levels of BRUCE/Apollon, which stimulates LC3-I degradation.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31213539","citation_count":50,"is_preprint":false},{"pmid":"32297303","id":"PMC_32297303","title":"CircRNA BIRC6 promotes non-small cell lung cancer cell progression by sponging microRNA-145.","date":"2020","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/32297303","citation_count":44,"is_preprint":false},{"pmid":"23287853","id":"PMC_23287853","title":"Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.","date":"2013","source":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23287853","citation_count":43,"is_preprint":false},{"pmid":"31935634","id":"PMC_31935634","title":"MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis.","date":"2020","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31935634","citation_count":42,"is_preprint":false},{"pmid":"25733871","id":"PMC_25733871","title":"BRUCE regulates DNA double-strand break response by promoting USP8 deubiquitination of BRIT1.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25733871","citation_count":41,"is_preprint":false},{"pmid":"7796401","id":"PMC_7796401","title":"Initiatives with platinum- and quinazoline-based antitumor molecules--Fourteenth Bruce F. Cain Memorial Award Lecture.","date":"1995","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/7796401","citation_count":41,"is_preprint":false},{"pmid":"25196217","id":"PMC_25196217","title":"BIRC6 promotes hepatocellular carcinogenesis: interaction of BIRC6 with p53 facilitating p53 degradation.","date":"2014","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25196217","citation_count":40,"is_preprint":false},{"pmid":"36758106","id":"PMC_36758106","title":"Structural basis for SMAC-mediated antagonism of caspase inhibition by the giant ubiquitin ligase BIRC6.","date":"2023","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/36758106","citation_count":37,"is_preprint":false},{"pmid":"35964136","id":"PMC_35964136","title":"Circular RNA BIRC6 depletion promotes osteogenic differentiation of periodontal ligament stem cells via the miR-543/PTEN/PI3K/AKT/mTOR signaling pathway in the inflammatory microenvironment.","date":"2022","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35964136","citation_count":37,"is_preprint":false},{"pmid":"9766639","id":"PMC_9766639","title":"Translational research: walking the bridge between idea and cure--seventeenth Bruce F. Cain Memorial Award lecture.","date":"1998","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9766639","citation_count":36,"is_preprint":false},{"pmid":"23409057","id":"PMC_23409057","title":"BIRC6 protein, an inhibitor of apoptosis: role in survival of human prostate cancer cells.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23409057","citation_count":35,"is_preprint":false},{"pmid":"36758104","id":"PMC_36758104","title":"Structures of BIRC6-client complexes provide a mechanism of SMAC-mediated release of caspases.","date":"2023","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/36758104","citation_count":34,"is_preprint":false},{"pmid":"27388765","id":"PMC_27388765","title":"miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27388765","citation_count":30,"is_preprint":false},{"pmid":"25071009","id":"PMC_25071009","title":"The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25071009","citation_count":30,"is_preprint":false},{"pmid":"27663589","id":"PMC_27663589","title":"BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer.","date":"2016","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/27663589","citation_count":29,"is_preprint":false},{"pmid":"12140330","id":"PMC_12140330","title":"BRUCE: a program for the detection of transfer-messenger RNA genes in nucleotide sequences.","date":"2002","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/12140330","citation_count":29,"is_preprint":false},{"pmid":"18566603","id":"PMC_18566603","title":"Prostaglandin F2alpha promotes muscle cell survival and growth through upregulation of the inhibitor of apoptosis protein BRUCE.","date":"2008","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/18566603","citation_count":28,"is_preprint":false},{"pmid":"33061425","id":"PMC_33061425","title":"Paclitaxel Suppresses Hepatocellular Carcinoma Tumorigenesis Through Regulating Circ-BIRC6/miR-877-5p/YWHAZ Axis.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33061425","citation_count":27,"is_preprint":false},{"pmid":"30693543","id":"PMC_30693543","title":"The BRUCE-ATR Signaling Axis Is Required for Accurate DNA Replication and Suppression of Liver Cancer Development.","date":"2019","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/30693543","citation_count":27,"is_preprint":false},{"pmid":"22788920","id":"PMC_22788920","title":"Identification of BIRC6 as a novel intervention target for neuroblastoma therapy.","date":"2012","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22788920","citation_count":26,"is_preprint":false},{"pmid":"15887267","id":"PMC_15887267","title":"Progressive loss of the spongiotrophoblast layer of Birc6/Bruce mutants results in embryonic lethality.","date":"2005","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/15887267","citation_count":26,"is_preprint":false},{"pmid":"21886178","id":"PMC_21886178","title":"Drosophila BRUCE inhibits apoptosis through non-lysine ubiquitination of the IAP-antagonist REAPER.","date":"2011","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/21886178","citation_count":26,"is_preprint":false},{"pmid":"29929453","id":"PMC_29929453","title":"The anti-apoptotic ubiquitin conjugating enzyme BIRC6/BRUCE regulates autophagosome-lysosome fusion.","date":"2018","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/29929453","citation_count":23,"is_preprint":false},{"pmid":"24453032","id":"PMC_24453032","title":"Expression and clinical significance of BIRC6 in human epithelial ovarian cancer.","date":"2014","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24453032","citation_count":23,"is_preprint":false},{"pmid":"29123378","id":"PMC_29123378","title":"10H-3,6-Diazaphenothiazine induces G2/M phase cell cycle arrest and caspase-dependent apoptosis and inhibits cell invasion of A2780 ovarian carcinoma cells through the regulation of NF-κB and (BIRC6-XIAP) complexes.","date":"2017","source":"Drug design, development and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29123378","citation_count":23,"is_preprint":false},{"pmid":"20188030","id":"PMC_20188030","title":"Depletion of BIRC6 leads to retarded bovine early embryonic development and blastocyst formation in vitro.","date":"2010","source":"Reproduction, fertility, and development","url":"https://pubmed.ncbi.nlm.nih.gov/20188030","citation_count":21,"is_preprint":false},{"pmid":"16792666","id":"PMC_16792666","title":"The contribution of Bruce Glick to the definition of the role played by the bursa of Fabricius in the development of the B cell lineage.","date":"2006","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16792666","citation_count":21,"is_preprint":false},{"pmid":"29033330","id":"PMC_29033330","title":"Exocrine Gland-Secreting Peptide 1 Is a Key Chemosensory Signal Responsible for the Bruce Effect in Mice.","date":"2017","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/29033330","citation_count":21,"is_preprint":false},{"pmid":"38291026","id":"PMC_38291026","title":"Molecular mechanisms underlying the BIRC6-mediated regulation of apoptosis and autophagy.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38291026","citation_count":20,"is_preprint":false},{"pmid":"31091257","id":"PMC_31091257","title":"Loss of BRUCE reduces cellular energy level and induces autophagy by driving activation of the AMPK-ULK1 autophagic initiating axis.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31091257","citation_count":20,"is_preprint":false},{"pmid":"28520795","id":"PMC_28520795","title":"BIRC6 mediates imatinib resistance independently of Mcl-1.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28520795","citation_count":18,"is_preprint":false},{"pmid":"19527720","id":"PMC_19527720","title":"Dexamethasone regulates expression of BRUCE/Apollon and the proliferation of neural progenitor cells.","date":"2009","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/19527720","citation_count":18,"is_preprint":false},{"pmid":"22016382","id":"PMC_22016382","title":"Oestradiol treatment restores the capacity of castrated males to induce both the Vandenbergh and the Bruce effects in mice (Mus musculus).","date":"2011","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22016382","citation_count":18,"is_preprint":false},{"pmid":"29764561","id":"PMC_29764561","title":"MiR-204 acts as a potential therapeutic target in acute myeloid leukemia by increasing BIRC6-mediated apoptosis.","date":"2018","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/29764561","citation_count":17,"is_preprint":false},{"pmid":"32214823","id":"PMC_32214823","title":"Long Non-Coding RNA DLEU1 Up-Regulates BIRC6 Expression by Competitively Sponging miR-381-3p to Promote Cisplatin Resistance in Nasopharyngeal Carcinoma.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32214823","citation_count":16,"is_preprint":false},{"pmid":"35655933","id":"PMC_35655933","title":"Cellular and immunometabolic mechanisms of inflammation in depression: Preliminary findings from single cell RNA sequencing and a tribute to Bruce McEwen.","date":"2022","source":"Neurobiology of stress","url":"https://pubmed.ncbi.nlm.nih.gov/35655933","citation_count":16,"is_preprint":false},{"pmid":"32017818","id":"PMC_32017818","title":"Analysis of the expression of BAX, BCL2, BIRC6, CASP3, CASP9 apoptosis genes during the first episode of schizophrenia.","date":"2019","source":"Psychiatria polska","url":"https://pubmed.ncbi.nlm.nih.gov/32017818","citation_count":16,"is_preprint":false},{"pmid":"35734023","id":"PMC_35734023","title":"Impact of stress on inhibitory neuronal circuits, our tribute to Bruce McEwen.","date":"2022","source":"Neurobiology of stress","url":"https://pubmed.ncbi.nlm.nih.gov/35734023","citation_count":16,"is_preprint":false},{"pmid":"34729249","id":"PMC_34729249","title":"Overexpression of BIRC6 driven by EGF-JNK-HECTD1 signaling is a potential therapeutic target for triple-negative breast cancer.","date":"2021","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/34729249","citation_count":15,"is_preprint":false},{"pmid":"33177288","id":"PMC_33177288","title":"Depletion of circ-BIRC6, a circular RNA, suppresses non-small cell lung cancer progression by targeting miR-4491.","date":"2020","source":"Bioscience trends","url":"https://pubmed.ncbi.nlm.nih.gov/33177288","citation_count":13,"is_preprint":false},{"pmid":"34542161","id":"PMC_34542161","title":"Silencing circ‑BIRC6 inhibits the proliferation, invasion, migration and epithelial‑mesenchymal transition of bladder cancer cells by targeting the miR‑495‑3p/XBP1 signaling axis.","date":"2021","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/34542161","citation_count":13,"is_preprint":false},{"pmid":"34354038","id":"PMC_34354038","title":"BRUCE silencing leads to axonal dystrophy by repressing autophagosome-lysosome fusion in Alzheimer's disease.","date":"2021","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/34354038","citation_count":13,"is_preprint":false},{"pmid":"16236253","id":"PMC_16236253","title":"Bruce/apollon promotes hippocampal neuron survival and is downregulated by kainic acid.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16236253","citation_count":13,"is_preprint":false},{"pmid":"25118708","id":"PMC_25118708","title":"Association of a polymorphism in the BIRC6 gene with pseudoexfoliative glaucoma.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25118708","citation_count":12,"is_preprint":false},{"pmid":"32697959","id":"PMC_32697959","title":"Bioactivity and cytotoxicity profiling of vincosamide and strictosamide, anthelmintic epimers from Sarcocephalus latifolius (Smith) Bruce leaf.","date":"2020","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32697959","citation_count":12,"is_preprint":false},{"pmid":"26683461","id":"PMC_26683461","title":"The UBC Domain Is Required for BRUCE to Promote BRIT1/MCPH1 Function in DSB Signaling and Repair Post Formation of BRUCE-USP8-BRIT1 Complex.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26683461","citation_count":12,"is_preprint":false},{"pmid":"23343397","id":"PMC_23343397","title":"Redescription and genetic characterization of Hysterothylacium thalassini Bruce, 1990 (Nematoda: Anisakidae) from marine fishes in the South China Sea.","date":"2013","source":"The Journal of parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/23343397","citation_count":12,"is_preprint":false},{"pmid":"27876095","id":"PMC_27876095","title":"Asymmetric hybridization between non-native winter moth, Operophtera brumata (Lepidoptera: Geometridae), and native Bruce spanworm, Operophtera bruceata, in the Northeastern United States, assessed with novel microsatellites and SNPs.","date":"2016","source":"Bulletin of entomological research","url":"https://pubmed.ncbi.nlm.nih.gov/27876095","citation_count":11,"is_preprint":false},{"pmid":"26191375","id":"PMC_26191375","title":"Knockdown of the Inhibitor of Apoptosis BRUCE Sensitizes Resistant Breast Cancer Cells to Chemotherapeutic Agents.","date":"2015","source":"Journal of cancer science & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/26191375","citation_count":11,"is_preprint":false},{"pmid":"35863430","id":"PMC_35863430","title":"A new circular RNA-encoded protein BIRC6-236aa inhibits transmissible gastroenteritis virus (TGEV)-induced mitochondrial dysfunction.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35863430","citation_count":9,"is_preprint":false},{"pmid":"32139899","id":"PMC_32139899","title":"BRUCE preserves genomic stability in the male germline of mice.","date":"2020","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/32139899","citation_count":9,"is_preprint":false},{"pmid":"22196277","id":"PMC_22196277","title":"RNA interference-mediated validation of survivin and Apollon/BRUCE as new therapeutic targets for cancer therapy.","date":"2012","source":"Current topics in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22196277","citation_count":9,"is_preprint":false},{"pmid":"31885751","id":"PMC_31885751","title":"Circ_MDM2_000139, Circ_ATF2_001418, Circ_CDC25C_002079, and Circ_BIRC6_001271 Are Involved in the Functions of XAV939 in Non-Small Cell Lung Cancer.","date":"2019","source":"Canadian respiratory journal","url":"https://pubmed.ncbi.nlm.nih.gov/31885751","citation_count":9,"is_preprint":false},{"pmid":"38066801","id":"PMC_38066801","title":"Evaluation of BIRC6 Expression in Oral Squamous Cell Carcinoma, Epithelial Dysplasia, Lichen Planus with and without Dysplasia, and Hyperkeratosis.","date":"2023","source":"Diagnostics (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/38066801","citation_count":8,"is_preprint":false},{"pmid":"27614745","id":"PMC_27614745","title":"BRUCE Protein, New Marker for Targeted Therapy of Gastric Carcinoma.","date":"2017","source":"Journal of gastrointestinal cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27614745","citation_count":8,"is_preprint":false},{"pmid":"23211188","id":"PMC_23211188","title":"BIRC6 (APOLLON) is down-regulated in acute myeloid leukemia and its knockdown attenuates neutrophil differentiation.","date":"2012","source":"Experimental hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23211188","citation_count":8,"is_preprint":false},{"pmid":"32851903","id":"PMC_32851903","title":"Reflections on Bruce S. McEwen's contributions to stress neurobiology and so much more.","date":"2020","source":"Stress (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/32851903","citation_count":8,"is_preprint":false},{"pmid":"33317170","id":"PMC_33317170","title":"BIRC6 Is Associated with Vulnerability of Carotid Atherosclerotic Plaque.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33317170","citation_count":7,"is_preprint":false},{"pmid":"35866869","id":"PMC_35866869","title":"BIRC6 modifies risk of invasive bacterial infection in Kenyan children.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/35866869","citation_count":6,"is_preprint":false},{"pmid":"38405482","id":"PMC_38405482","title":"BIRC6 Modulates the Protein Stability of Axin to Regulate the Growth, Stemness, and Resistance of Renal Cancer Cells via the β-Catenin Pathway.","date":"2024","source":"ACS omega","url":"https://pubmed.ncbi.nlm.nih.gov/38405482","citation_count":6,"is_preprint":false},{"pmid":"36033570","id":"PMC_36033570","title":"Oral Squamous Cell Carcinoma: The Role of BIRC6 Serum Level.","date":"2022","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/36033570","citation_count":5,"is_preprint":false},{"pmid":"27649954","id":"PMC_27649954","title":"Expression analysis of BRUCE protein in esophageal squamous cell carcinoma.","date":"2016","source":"Annals of diagnostic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/27649954","citation_count":5,"is_preprint":false},{"pmid":"41350950","id":"PMC_41350950","title":"UBA6 specificity for ubiquitin E2 conjugating enzymes reveals a priority mechanism of BIRC6.","date":"2025","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/41350950","citation_count":5,"is_preprint":false},{"pmid":"36455174","id":"PMC_36455174","title":"Exploring the Role of the Inhibitor of Apoptosis BIRC6 in Breast Cancer: A Database Analysis.","date":"2022","source":"JCO clinical cancer informatics","url":"https://pubmed.ncbi.nlm.nih.gov/36455174","citation_count":4,"is_preprint":false},{"pmid":"25138702","id":"PMC_25138702","title":"Apollon/Bruce is upregulated by Humanin.","date":"2014","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25138702","citation_count":4,"is_preprint":false},{"pmid":"39705142","id":"PMC_39705142","title":"The differential interactomes of the KRAS splice variants identify BIRC6 as a ubiquitin ligase for KRAS4A.","date":"2024","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/39705142","citation_count":4,"is_preprint":false},{"pmid":"31827407","id":"PMC_31827407","title":"Nrdp1 increases neuron apoptosis via downregulation of Bruce following intracerebral haemorrhage.","date":"2019","source":"Journal of inflammation (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31827407","citation_count":4,"is_preprint":false},{"pmid":"34083041","id":"PMC_34083041","title":"Bruce Nathan Ames - Paradigm shifts inside the cancer research revolution.","date":"2020","source":"Mutation research. Reviews in mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/34083041","citation_count":4,"is_preprint":false},{"pmid":"19198067","id":"PMC_19198067","title":"Regulation of apoptosis and cytokinesis by the anti-apoptotic E2/E3 ubiquitin-ligase BRUCE.","date":"2008","source":"Ernst Schering Foundation symposium proceedings","url":"https://pubmed.ncbi.nlm.nih.gov/19198067","citation_count":4,"is_preprint":false},{"pmid":"31585631","id":"PMC_31585631","title":"A personally guided tour on some of our data with the Ames assay-A tribute to Professor Bruce Ames.","date":"2019","source":"Mutation research. Genetic toxicology and environmental mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/31585631","citation_count":4,"is_preprint":false},{"pmid":"33815677","id":"PMC_33815677","title":"BIR repeat-containing ubiquitin conjugating enzyme (BRUCE) regulation of β-catenin signaling in the progression of drug-induced hepatic fibrosis and carcinogenesis.","date":"2021","source":"World journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/33815677","citation_count":3,"is_preprint":false},{"pmid":"27446249","id":"PMC_27446249","title":"Nrdp1-mediated degradation of BRUCE decreases cell viability and induces apoptosis in human 786-O renal cell carcinoma cells.","date":"2016","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27446249","citation_count":3,"is_preprint":false},{"pmid":"30136341","id":"PMC_30136341","title":"Using the SSU, ITS, and Ribosomal DNA Operon Arrangement to Characterize Two Microsporidia Infecting Bruce Spanworm, Operophtera bruceata (Lepidoptera: Geometridae).","date":"2018","source":"The Journal of eukaryotic microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/30136341","citation_count":3,"is_preprint":false},{"pmid":"3229446","id":"PMC_3229446","title":"The male-induced implantation failure (the Bruce effect) in laboratory mice: investigations on luteal failure in pregnancy-blocked females.","date":"1988","source":"Experimental and clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/3229446","citation_count":3,"is_preprint":false},{"pmid":"7235620","id":"PMC_7235620","title":"Evidence for the involvement of serotoninergic system in the male-induced ovo-implantation failure (Bruce effect) in mice.","date":"1980","source":"Annales d'endocrinologie","url":"https://pubmed.ncbi.nlm.nih.gov/7235620","citation_count":3,"is_preprint":false},{"pmid":"33243730","id":"PMC_33243730","title":"[Effect of small interfering RNA-mediated BIRC6 silencing on apoptosis and autophagy of renal cancer 786-O cells].","date":"2020","source":"Nan fang yi ke da xue xue bao = Journal of Southern Medical University","url":"https://pubmed.ncbi.nlm.nih.gov/33243730","citation_count":2,"is_preprint":false},{"pmid":"38046892","id":"PMC_38046892","title":"The Media Coverage of Bruce Willis Reveals Unfamiliarity With Frontotemporal Degeneration.","date":"2023","source":"Innovation in aging","url":"https://pubmed.ncbi.nlm.nih.gov/38046892","citation_count":2,"is_preprint":false},{"pmid":"33261220","id":"PMC_33261220","title":"A Wide Frequency Scanning Printed Bruce Array Antenna with Bowtie and Semi-Circular Elements.","date":"2020","source":"Sensors (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/33261220","citation_count":2,"is_preprint":false},{"pmid":"9527909","id":"PMC_9527909","title":"Volume 8, Number 2 (1997): Kyung-Eui Ro, Carl S. Keener, and Bruce A. McPheron, \"Molecular Phylogenetic Study of the Ranunculaceae: Utility of the Nuclear 26S Ribosomal DNA in Inferring Intrafamilial Relationships,\" pp. 117-127:","date":"1998","source":"Molecular phylogenetics and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/9527909","citation_count":2,"is_preprint":false},{"pmid":"20041659","id":"PMC_20041659","title":"Improved synthesis of (3E,6Z,9Z)-1,3,6,9-nonadecatetraene, attraction inhibitor of bruce spanworm, Operophtera bruceata, to pheromone traps for monitoring winter moth, Operophtera brumata.","date":"2010","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20041659","citation_count":2,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48673,"output_tokens":8039,"usd":0.133302,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17646,"output_tokens":4484,"usd":0.100165,"stage2_stop_reason":"end_turn"},"total_usd":0.233467,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"BIRC6/BRUCE functions as a chimeric E2/E3 ubiquitin ligase and IAP: it inhibits caspase activity and apoptosis via its BIR domain, is antagonized by Smac binding, by HtrA2 protease cleavage, and by caspase-mediated cleavage, and ubiquitinates Smac as a substrate. BRUCE localizes to the trans-Golgi network as a peripheral membrane protein.\",\n      \"method\": \"Wild-type and mutant BRUCE constructs, Co-IP, in vitro ubiquitination assay, apoptosis assays, subcellular fractionation/localization\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (mutagenesis, in vitro ubiquitination, Co-IP, localization) in a single rigorous study; key findings replicated by independent labs\",\n      \"pmids\": [\"15200957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"BRUCE/Apollon associates with both precursor and mature forms of Smac and caspase-9 (binding regions beyond the IAP-binding motif), promotes proteasomal degradation of Smac, and inhibits caspase-9 activity but not caspase-3 activity. Upon apoptotic stimuli, BRUCE is degraded by proteasomes and/or cleaved by caspases or HtrA2 depending on stimulus and cell type.\",\n      \"method\": \"Co-immunoprecipitation, in vitro caspase activity assays, proteasome inhibitor experiments, cell-based apoptosis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP plus functional enzymatic assays; independently consistent with Bartke et al. 2004\",\n      \"pmids\": [\"15507451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Nrdp1/FLRF, a RING-finger E3 ubiquitin ligase, associates with BRUCE and, in the presence of exogenous E2 UbcH5c, catalyzes BRUCE ubiquitination in vitro. Nrdp1 overexpression promotes BRUCE ubiquitination and proteasomal degradation in vivo; RNAi knockdown of Nrdp1 reduces apoptosis-induced BRUCE loss. Thus Nrdp1 is a writer that targets BRUCE for degradation to promote apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, in vitro ubiquitination assay with purified proteins, RNAi knockdown, proteasome inhibitor experiments\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro reconstitution with purified proteins plus cellular RNAi confirmation; replicated in subsequent studies\",\n      \"pmids\": [\"14765125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Deletion of the C-terminal half of BRUCE (including the UBC domain) in mice activates caspases and apoptosis in placenta/yolk sac causing embryonic lethality, associated with p53 nuclear localization, upregulation of Bax, Bak, Pidd, mitochondrial translocation of Bax and caspase-2, cytochrome c and AIF release, and caspase-9/-3 activation. p53 RNAi rescue in human H460 cells confirms p53 is a downstream effector of BRUCE in the mitochondrial apoptosis pathway.\",\n      \"method\": \"Conditional knockout mouse, RNAi rescue in cell lines, Western blot, immunofluorescence, caspase activity assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic knockout plus orthogonal RNAi rescue with mechanistic pathway dissection\",\n      \"pmids\": [\"15640352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"BRUCE-deficient mice die perinatally with growth retardation linked to impaired placental labyrinth maturation and spongiotrophoblast reduction; no elevated apoptosis was detected in knockout tissues or fibroblasts, suggesting a role in placental/trophoblast differentiation distinct from anti-apoptotic function.\",\n      \"method\": \"Gene targeting/knockout mouse, histology, TUNEL apoptosis assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockout with defined cellular phenotype; independently replicated by Hitz et al. 2005 and Ren et al. 2005\",\n      \"pmids\": [\"15485903\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BRUCE is a major regulator of cytokinesis abscission: during cytokinesis it relocates from vesicular/trans-Golgi network compartments to the midbody ring, serving as a platform for membrane delivery machinery and mitotic regulators. BRUCE depletion causes defective abscission, cytokinesis-associated apoptosis, blocked vesicular targeting, and defective midbody ring formation. Ubiquitin relocalizes from midbody microtubules to the midbody ring during cytokinesis, and BRUCE depletion disrupts this ubiquitin relocalization.\",\n      \"method\": \"RNAi depletion in cell culture, live-cell imaging, immunofluorescence, electron microscopy, co-localization studies\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean RNAi with defined cellular phenotype, multiple imaging modalities, mechanistic dissection of ubiquitin dynamics\",\n      \"pmids\": [\"18329369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"BRUCE acts as a scaffold bridging USP8 and BRIT1 in a nuclear complex; it promotes USP8-catalyzed deubiquitination of K63-ubiquitinated BRIT1, which is a prerequisite for BRIT1 recruitment to DNA double-strand breaks (DSBs) via γ-H2AX. Loss of BRUCE impairs BRIT1 deubiquitination, BRIT1-γH2AX binding, BRIT1 DSB foci, chromatin relaxation, and homologous recombination repair. BRUCE-mutant mice show genomic instability.\",\n      \"method\": \"Co-immunoprecipitation, in vitro deubiquitination assay, RNAi knockdown, immunofluorescence foci assays, HR repair assay, mouse genetics\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — biochemical complex reconstitution by Co-IP, functional HR assay, in vivo mouse model, multiple orthogonal methods\",\n      \"pmids\": [\"25733871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The UBC (E2) domain of BRUCE, but not its BIR domain, is required for BRIT1 deubiquitination and recruitment to DSBs: UBC domain mutation or deletion does not disrupt the BRUCE-USP8-BRIT1 complex but impairs downstream deubiquitination and DSB repair, implicating BRUCE's E3 ligase activity in facilitating USP8-mediated deubiquitination.\",\n      \"method\": \"Domain deletion/point mutation analysis, Co-IP, γ-H2AX/BRIT1 foci assays, HR repair assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single lab, but multiple orthogonal assays with domain mutants supporting mechanistic conclusion\",\n      \"pmids\": [\"26683461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BIRC6/BRUCE positively regulates autophagosome-lysosome fusion: BRUCE depletion leads to defective autophagosome-lysosome fusion. BRUCE selectively interacts with ATG8 family members GABARAP and GABARAPL1, and with Syntaxin 17 (STX17), all critical regulators of autophagosome-lysosome fusion. BRUCE co-localizes with LAMP2 (lysosomal marker). A non-catalytic N-terminal fragment lacking the UBC domain rescues autolysosome formation in Bruce-/- cells, indicating this role is independent of ubiquitin-conjugating activity.\",\n      \"method\": \"RNAi screen, Co-immunoprecipitation, autophagy flux assays (tandem fluorescent LC3), immunofluorescence co-localization, domain deletion rescue experiments\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, functional rescue with domain mutant, multiple orthogonal autophagy assays; independently replicated by Ikeda 2018 commentary and other groups\",\n      \"pmids\": [\"29426817\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"UBA6 and BIRC6 cooperate to monoubiquitinate LC3B, targeting it for proteasomal degradation, thereby negatively regulating autophagy. Knockout of UBA6 or BIRC6 increases autophagic flux under nutrient deprivation or protein synthesis inhibition, decreases aggresome-like structures and α-synuclein aggregates.\",\n      \"method\": \"Whole-genome CRISPR/Cas9 knockout screen, genetic rescue, autophagic flux assays (tandem GFP-mCherry-LC3B), immunoprecipitation, proteasome inhibitor experiments\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — unbiased CRISPR screen followed by mechanistic validation with multiple orthogonal assays; UBA6-BIRC6 E1-E2 pairing confirmed biochemically\",\n      \"pmids\": [\"31692446\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"BRUCE together with proteasome activator PA28γ promotes proteasomal degradation of LC3-I, inhibiting autophagy initiation. SIP/CacyBP inhibits Nrdp1-mediated ubiquitination of BRUCE under normal conditions, thereby protecting BRUCE. Upon starvation, SIP together with Rab8 promotes translocation of BRUCE into recycling endosomes and autophagic degradation of BRUCE by optineurin-mediated autophagy, thus relieving BRUCE-dependent LC3-I degradation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro ubiquitination assay, autophagy flux assays, confocal microscopy, RNAi knockdown, cell fractionation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Co-IP, biochemical assays, live imaging) in a single mechanistic study\",\n      \"pmids\": [\"31213539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"BRUCE is required for ATR activation during replication stress: BRUCE is recruited to DNA damage sites, and BRUCE depletion impairs ATR activation, phosphorylation of CHK1 and RPA, and monoubiquitination of FANCD2, resulting in stalled replication forks and increased replication origin firing. Liver-specific Bruce knockout in mice impairs ATR activation and promotes hepatocellular carcinoma development.\",\n      \"method\": \"RNAi depletion, immunofluorescence, Western blot for ATR-pathway markers, DNA fiber assay, liver-specific conditional knockout mouse, diethylnitrosamine carcinogenesis model\",\n      \"journal\": \"Hepatology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vitro mechanistic evidence plus in vivo genetic validation with multiple pathway readouts\",\n      \"pmids\": [\"30693543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"BRUCE depletion lowers cellular ATP/AMP ratio, activating AMPK (pThr-172) and downstream ULK1 (pSer-555), which induces autophagy independently of starvation. This energy-sensing pathway establishes a BRUCE-AMPK-ULK1 axis in autophagy regulation.\",\n      \"method\": \"RNAi knockdown, AMP/ATP ratio measurement, Western blot for AMPK and ULK1 phosphorylation, LC3 puncta quantification, autophagy flux assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single lab, multiple biochemical readouts supporting AMPK-ULK1 axis but no direct BRUCE-AMPK interaction demonstrated\",\n      \"pmids\": [\"31091257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Drosophila BRUCE (dBruce) physically interacts with the IAP-antagonist Reaper via Reaper's IBM and GH3 motifs and promotes Reaper ubiquitination on unconventional non-lysine acceptor sites (as demonstrated with lysine-deficient Reaper mutants). Loss of dBruce elevates Reaper protein levels, indicating BRUCE inhibits apoptosis by targeting IAP-antagonists for ubiquitination.\",\n      \"method\": \"Co-immunoprecipitation, in vitro ubiquitination assay with lysine-deficient substrates, genetic loss-of-function (dBruce-/- background), RNAi knockdown\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — biochemical reconstitution of ubiquitination on defined substrate mutants plus genetic validation\",\n      \"pmids\": [\"21886178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Prostaglandin F2alpha (PGF2alpha) increases BRUCE expression in skeletal myoblasts via the NFAT2 transcription factor pathway, and PGF2alpha-mediated reduction of muscle cell death during myogenesis is dependent on BRUCE. Overexpression of BRUCE alone is sufficient to promote muscle cell survival and myotube growth.\",\n      \"method\": \"In vitro myogenesis, siRNA knockdown, BRUCE overexpression, NFAT2 inhibitor experiments, in vivo muscle injury model\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — single lab, multiple assays (KD, OE, in vivo) but NFAT2-BRUCE transcriptional link not directly shown by promoter assay\",\n      \"pmids\": [\"18566603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Cryo-EM structures of full-length human BIRC6 reveal it forms an antiparallel homodimer arranged in a megadalton crescent shape with a central cavity containing receptor sites for client proteins (caspase-9, HTRA2, SMAC, LC3B). BIRC6 directly restricts executioner caspases-3 and -7, ubiquitinates caspases-3, -7, and -9 exclusively via the noncanonical E1 UBA6. SMAC binds BIRC6 at multiple sites with subnanomolar affinity, competitively displacing caspases and thus antagonizing BIRC6 anti-caspase function. SMAC binding to BIRC6 obstructs client binding, impeding ubiquitination of both apoptotic and autophagic substrates.\",\n      \"method\": \"Cryo-electron microscopy structure determination, in vitro ubiquitination assays, binding competition assays, structure-function mutagenesis\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — three independent cryo-EM structural studies in the same issue, with functional validation by in vitro assays; orthogonal studies (PMIDs 36758104, 36758105, 36758106) provide convergent structural and biochemical evidence\",\n      \"pmids\": [\"36758105\", \"36758104\", \"36758106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BIRC6 forms an anti-parallel U-shaped dimer with multiple previously unannotated domains including a ubiquitin-like domain. Smac/DIABLO outcompetes effector caspase-3 and HtrA2 but not procaspase-9 for binding to the BIRC6 central cavity. BIRC6 binds LC3 through an LC3-interacting region (LIR), and mutation of the LC3 ubiquitylation site promotes autophagy and autophagic degradation of BIRC6. Induction of autophagy promotes autophagic degradation of BIRC6 and caspase-9 but not other effector caspases.\",\n      \"method\": \"Cryo-EM structure, in vitro binding competition assays, site-directed mutagenesis, autophagy flux assays, Co-immunoprecipitation\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cryo-EM plus functional mutagenesis and binding assays in single study; consistent with independent structural studies\",\n      \"pmids\": [\"38291026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"BIRC6 is a UBA6-exclusive E2 enzyme that gains priority over all other UBA6-competent E2s through an exceptionally high-affinity interaction driven by BIRC6 engagement with the UBA6 ubiquitin fold domain (modulated by the UBA6 Cys-Cap loop). BIRC6 uses a bespoke thioester switch mechanism to disengage from UBA6 upon receiving ubiquitin, preventing UBA6 inhibition. This E1-E2 priority underpins BIRC6's functional importance in regulating cell death, embryogenesis, and autophagy.\",\n      \"method\": \"Structural capture of BIRC6-UBA6 complex in multiple states (cryo-EM/crystallography), in vitro ubiquitin transfer assays, mutagenesis of UBA6 Cys-Cap loop, E2 competition assays\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — structural determination with functional reconstitution and mutagenesis in a single rigorous study\",\n      \"pmids\": [\"41350950\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"BIRC6 interacts with p53 and facilitates its ubiquitin-proteasome-mediated degradation in hepatocellular carcinoma cells. BIRC6 knockdown stabilizes p53, and RNA interference targeting p53 partially reverses the pro-apoptotic effects of BIRC6 depletion.\",\n      \"method\": \"Co-immunoprecipitation, Western blot, siRNA knockdown, lentiviral shRNA, in vivo xenograft\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP plus functional RNAi rescue; single lab, no in vitro ubiquitination reconstitution\",\n      \"pmids\": [\"25196217\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BIRC6 stability is regulated by the Src-family kinase Lyn: RNAi knockdown or pharmacological inhibition of Lyn reduces BIRC6 protein stability and increases formation of an N-terminal BIRC6 cleavage fragment, coinciding with reduced BIRC6 phosphopeptide (S480/S482/S486), suggesting Lyn-dependent phosphorylation stabilizes BIRC6.\",\n      \"method\": \"Phosphoproteomic mass spectrometry, RNAi knockdown, kinase inhibitors (dasatinib/ponatinib), Western blot\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — phosphoproteomics identification plus functional knockdown validation; single lab, no direct in vitro kinase assay\",\n      \"pmids\": [\"28520795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BIRC6 stability is increased by EGF-JNK signaling, which prevents BIRC6 ubiquitination and degradation mediated by the E3 ubiquitin ligase HECTD1. BIRC6 in turn decreases SMAC expression by inducing the ubiquitin-proteasome pathway in TNBC cells.\",\n      \"method\": \"Co-immunoprecipitation, Western blot, siRNA knockdown, EGF/JNK pathway inhibitors, in vivo xenograft\",\n      \"journal\": \"Molecular therapy. Nucleic acids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP and pathway inhibitor evidence in a single lab; HECTD1-BIRC6 direct ubiquitination not reconstituted in vitro\",\n      \"pmids\": [\"34729249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In hepatocytes, BRUCE co-localizes and interacts with PKA in the cytoplasm, suppressing PKA activity and thereby reducing PKA-dependent phosphorylation (Ser-675) and nuclear accumulation of β-catenin. BRUCE deficiency elevates PKA activity and pSer-675-β-catenin, establishing a BRUCE-PKA-β-catenin signaling axis in liver disease progression.\",\n      \"method\": \"Liver-specific conditional knockout mouse, Co-immunoprecipitation, kinase activity assay, Western blot, immunofluorescence\",\n      \"journal\": \"World journal of hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — in vivo genetic model plus biochemical Co-IP; direct BRUCE-PKA interaction not reconstituted in vitro\",\n      \"pmids\": [\"33815677\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BIRC6 interacts with KRAS4A (but not KRAS4B) on the Golgi apparatus and mono- and di-ubiquitinates KRAS4A at lysines 128 and 147. BIRC6 silencing diminishes GTP loading of KRAS4A and growth stimulation by KRAS4A but not KRAS4B.\",\n      \"method\": \"Proximity labeling (BioID), Co-immunoprecipitation, in vitro ubiquitination assay, mass spectrometry identification of ubiquitination sites, RNAi knockdown, GTP-loading assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — proximity labeling plus biochemical Co-IP and in vitro ubiquitination with site identification; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"39705142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In Bruce-/- male germline (conditional knockout), spermatogonia maintenance is impaired and meiotic spermatocytes show persistent DNA breaks, defective homologous synapsis, non-homologous chromosomal associations, and absent ATM/ATR signaling at unsynapsed regions, establishing BRUCE as essential for meiotic homologous recombination and genomic stability in the male germline.\",\n      \"method\": \"Conditional germline-specific knockout mouse, immunofluorescence with synapsis markers (SYCP1/3), γ-H2AX/RAD51 foci, ATM/ATR staining, chromosome spread analysis\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean conditional knockout with defined meiotic phenotype and multiple molecular markers\",\n      \"pmids\": [\"32139899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Drosophila BRUCE (dBruce) inhibits cell death induced by Reaper and Grim but not Hid using gain-of-function and loss-of-function alleles. The BIR domain alone is insufficient; the E2 domain is required. dBruce does not promote direct degradation of Rpr or Grim, but its activity requires their N-terminal IAP-binding motifs. dBruce does not block Dronc caspase or Debcl/dBorg.\",\n      \"method\": \"Drosophila gain-of-function transgenes, loss-of-function deletion alleles, genetic epistasis, in vivo cell death assays\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic epistasis with multiple alleles and substrate specificity mapping in vivo\",\n      \"pmids\": [\"12121627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"BIRC6 binds and degrades the cytoplasmic fraction of the pro-apoptotic protein DIABLO/Smac in neuroblastoma cells: BIRC6 silencing by shRNA increases DIABLO protein levels and induces apoptosis; Co-immunoprecipitation confirmed direct BIRC6-DIABLO interaction.\",\n      \"method\": \"Lentiviral shRNA knockdown, Co-immunoprecipitation, immunofluorescence, MTT apoptosis assay\",\n      \"journal\": \"BMC cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single Co-IP plus functional knockdown; consistent with in vitro biochemical data from other studies\",\n      \"pmids\": [\"22788920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Drosophila Bruce and the effector caspase Dcp-1 regulate starvation-induced autophagy during oogenesis in two nutrient checkpoints (germarium and mid-oogenesis), demonstrating that Bruce functions at the intersection of autophagy and apoptosis regulation in vivo.\",\n      \"method\": \"Systematic RNAi screen of cell death genes, genetic loss-of-function alleles, autophagy marker assays (ATG mutants), DNA fragmentation assay, oogenesis in vivo model\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — genetic screen with in vivo validation; mechanistic link between Bruce and autophagy molecular machinery not fully defined in this study alone\",\n      \"pmids\": [\"18794330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dexamethasone (acting via glucocorticoid receptor) decreases BRUCE expression in neural progenitor cells (NPCs) and reduces NPC proliferation; BRUCE overexpression counteracts dexamethasone-induced reduction. Dex also elevates Usp8/Ubpy which via Nrdp1 decreases BRUCE, suggesting a glucocorticoid-Nrdp1-BRUCE axis regulating NPC cell division.\",\n      \"method\": \"Glucocorticoid receptor antagonist (RU486), RNAi silencing, BRUCE overexpression, cell proliferation assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single lab, KD/OE with phenotypic readout; pathway placement partly inferred\",\n      \"pmids\": [\"19527720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2080,\n      \"finding\": \"BIRC6 modulates Axin protein stability via ubiquitination: BIRC6 interacts with Axin by co-immunoprecipitation, co-localizes with Axin in the cytoplasm, overexpression promotes Axin ubiquitination and degradation, and knockdown suppresses Axin ubiquitination, leading to β-catenin pathway activation in renal cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence co-localization, ubiquitination assay, siRNA knockdown, lentiviral overexpression, Western blot, in vivo xenograft with Wnt inhibitor\",\n      \"journal\": \"ACS omega\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP plus functional overexpression/knockdown; no in vitro reconstitution of direct ubiquitination; single lab\",\n      \"pmids\": [\"38405482\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BIRC6 (BRUCE/Apollon) is a ~528 kDa peripheral membrane protein of the trans-Golgi network that functions as both a BIR domain-containing inhibitor of apoptosis (IAP) and a chimeric E2/E3 ubiquitin ligase working exclusively with the noncanonical E1 enzyme UBA6; cryo-EM structures reveal it forms an antiparallel homodimer with a central cavity that binds and ubiquitinates pro-apoptotic clients (caspases-3, -7, -9, SMAC, HtrA2) and autophagic substrate LC3, while SMAC binding at multiple sites with subnanomolar affinity competitively displaces caspases to release apoptosis; beyond apoptosis regulation, BIRC6 promotes cytokinesis abscission by relocating to the midbody ring, facilitates DNA double-strand break repair by scaffolding USP8-mediated deubiquitination of BRIT1 and activating ATR signaling at stalled replication forks, regulates autophagosome-lysosome fusion by interacting with GABARAP/GABARAPL1 and Syntaxin 17 independently of its ubiquitin-conjugating activity, and is itself subject to regulated degradation by Nrdp1-mediated ubiquitination and by autophagic clearance.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"BIRC6 (BRUCE/Apollon) is a megadalton, trans-Golgi-associated protein that integrates apoptosis control, ubiquitin signaling, and autophagy through a single chimeric architecture combining a BIR domain with a ubiquitin-conjugating (UBC/E2) module [#0, #1]. As an inhibitor of apoptosis, it binds pro-apoptotic clients including caspase-9, SMAC/DIABLO, and HtrA2, restrains caspase activity, and targets clients such as SMAC for proteasomal degradation, with apoptotic signals in turn dismantling BIRC6 via caspase/HtrA2 cleavage and proteasomal turnover [#0, #1, #25]. Cryo-EM structures resolve BIRC6 as an antiparallel U-shaped homodimer enclosing a central cavity that houses receptor sites for caspase-9, HtrA2, SMAC, and LC3B; it directly restricts executioner caspases-3/-7 and ubiquitinates caspases-3/-7/-9 exclusively through the noncanonical E1 UBA6, while SMAC binds at multiple subnanomolar sites to competitively displace clients and relieve their inhibition [#15, #16]. BIRC6 is a UBA6-exclusive E2 that wins priority over other UBA6-competent E2 enzymes via a high-affinity interaction with the UBA6 ubiquitin-fold domain and a thioester-switch mechanism that disengages it upon ubiquitin loading [#17]. Beyond apoptosis, BIRC6 governs cytokinetic abscission by relocating from Golgi/vesicular compartments to the midbody ring [#5], supports DNA double-strand break repair by scaffolding USP8-mediated deubiquitination of BRIT1 and activating ATR signaling at stalled forks [#6, #7, #11], and is required for meiotic homologous recombination in the male germline [#23]. It bidirectionally regulates autophagy: it promotes autophagosome-lysosome fusion through ubiquitin-independent interactions with GABARAP/GABARAPL1 and Syntaxin 17 [#8], yet with UBA6 monoubiquitinates LC3B to drive its proteasomal degradation and negatively regulate autophagy [#9, #16]. BIRC6 abundance is itself tightly controlled by Nrdp1-mediated ubiquitination and by autophagic clearance [#2, #10]. Genetically, loss of BIRC6 function causes embryonic/perinatal lethality with placental defects in mice [#3, #4], and liver-specific deletion impairs ATR activation and promotes hepatocellular carcinoma [#11].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established the core dual identity of BIRC6 as both an IAP and a ubiquitin ligase, answering what kind of molecule BRUCE is and how it suppresses cell death.\",\n      \"evidence\": \"Wild-type/mutant constructs, in vitro ubiquitination, Co-IP, apoptosis assays, and subcellular fractionation defining BIR-dependent caspase inhibition, Smac/HtrA2/caspase antagonism, and trans-Golgi localization\",\n      \"pmids\": [\"15200957\", \"15507451\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which caspases are inhibited directly versus via ubiquitination\", \"E1 enzyme partner not identified at this stage\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified how BIRC6 levels are set, showing the RING E3 Nrdp1 ubiquitinates BRUCE for proteasomal degradation to license apoptosis.\",\n      \"evidence\": \"Co-IP, in vitro ubiquitination with purified proteins and UbcH5c, RNAi knockdown, and proteasome inhibition\",\n      \"pmids\": [\"14765125\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define stimuli triggering Nrdp1 engagement\", \"Ubiquitin chain linkage on BRUCE not characterized\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined the in vivo developmental requirement and downstream apoptotic pathway, showing C-terminal/UBC-domain loss triggers p53-dependent mitochondrial apoptosis and embryonic lethality.\",\n      \"evidence\": \"Conditional knockout mouse plus p53 RNAi rescue in H460 cells with caspase and mitochondrial readouts\",\n      \"pmids\": [\"15640352\", \"15485903\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Apparent discrepancy between apoptosis-driven lethality and apoptosis-independent placental differentiation defect not reconciled\", \"Direct p53 ubiquitination by BIRC6 not shown here\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Extended BIRC6 function beyond apoptosis to cell division, showing it relocates to the midbody ring to drive cytokinetic abscission and ubiquitin redistribution.\",\n      \"evidence\": \"RNAi depletion, live-cell imaging, immunofluorescence, and electron microscopy\",\n      \"pmids\": [\"18329369\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ubiquitination substrates at the midbody ring not identified\", \"Whether E2/E3 activity is required for abscission not resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Revealed a nuclear DNA-repair scaffold role, showing BIRC6 bridges USP8 and BRIT1 to enable BRIT1 deubiquitination and DSB recruitment via its UBC domain.\",\n      \"evidence\": \"Co-IP complex reconstitution, in vitro deubiquitination, HR repair assay, foci imaging, domain mutants, and mouse genetics\",\n      \"pmids\": [\"25733871\", \"26683461\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How an E2/E3 domain promotes a deubiquitination reaction mechanistically remains unclear\", \"Direct enzymatic substrate of BIRC6 in this complex not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed a ubiquitin-independent autophagy function, with BIRC6 promoting autophagosome-lysosome fusion via GABARAP/GABARAPL1 and STX17 interactions.\",\n      \"evidence\": \"RNAi screen, reciprocal Co-IP, tandem-fluorescent LC3 flux assays, LAMP2 co-localization, and non-catalytic N-terminal rescue\",\n      \"pmids\": [\"29426817\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of STX17/GABARAP binding not defined here\", \"Reconciliation with later negative regulation of autophagy not addressed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined an opposing, catalytic autophagy-suppressing role, showing UBA6-BIRC6 monoubiquitinates LC3B for degradation and that BIRC6 also acts through PA28γ, AMPK-ULK1 energy sensing, and ATR activation.\",\n      \"evidence\": \"Whole-genome CRISPR screen, IP, flux assays, AMP/ATP measurements, DNA fiber assays, and liver-specific knockout carcinogenesis model\",\n      \"pmids\": [\"31692446\", \"31213539\", \"31091257\", \"30693543\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the pro-fusion and anti-LC3 functions are balanced in cells is unresolved\", \"No direct BIRC6-AMPK interaction demonstrated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Provided the structural mechanism, resolving BIRC6 as an antiparallel homodimer whose central cavity houses client receptor sites and showing SMAC competitively displaces caspases at subnanomolar affinity.\",\n      \"evidence\": \"Three convergent cryo-EM studies with in vitro ubiquitination and binding competition assays\",\n      \"pmids\": [\"36758105\", \"36758104\", \"36758106\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo regulation of cavity occupancy not addressed\", \"Dynamics of client exchange in cells not measured\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Refined the structural model and substrate logic, identifying a ubiquitin-like domain and an LC3-interacting region, and showing differential SMAC competition and autophagic degradation of BIRC6 and caspase-9.\",\n      \"evidence\": \"Cryo-EM, binding competition, site-directed mutagenesis of the LC3 ubiquitylation site, and autophagy flux assays\",\n      \"pmids\": [\"38291026\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological trigger for switching between LC3 ubiquitination and BIRC6 autophagic clearance not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Expanded the substrate repertoire beyond apoptosis, showing BIRC6 selectively ubiquitinates KRAS4A at the Golgi to support its GTP loading and growth signaling.\",\n      \"evidence\": \"BioID proximity labeling, Co-IP, in vitro ubiquitination with site mapping, RNAi, and GTP-loading assay\",\n      \"pmids\": [\"39705142\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether KRAS4A ubiquitination is UBA6-dependent not stated\", \"Generality across cell types not established\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Explained how BIRC6 monopolizes ubiquitin charging, demonstrating it is a UBA6-exclusive E2 that outcompetes rival E2s and uses a thioester switch to avoid inhibiting the E1.\",\n      \"evidence\": \"Multi-state structural capture of the BIRC6-UBA6 complex, ubiquitin transfer assays, UBA6 Cys-Cap loop mutagenesis, and E2 competition assays\",\n      \"pmids\": [\"41350950\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How E1-E2 priority is regulated across cellular states not addressed\", \"Consequences for non-apoptotic substrates not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How BIRC6's competing roles—anti-apoptotic IAP, bidirectional autophagy regulator, cytokinesis and DNA-repair scaffold, and KRAS4A/Axin/p53 ubiquitin ligase—are coordinated and prioritized within a single cell remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No unified model integrating ubiquitin-dependent and ubiquitin-independent functions\", \"Tissue- and stimulus-specific substrate selection mechanisms undefined\", \"Several cancer-context substrates (Axin, p53, HECTD1 regulation) lack in vitro reconstitution\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 9, 15, 22]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [0, 15, 17]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 15, 16]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [6, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 5, 22]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [21, 25]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 1, 3, 15]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [8, 9, 10, 16]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [6, 7, 11, 23]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [2, 17]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"UBA6\", \"SMAC/DIABLO\", \"Caspase-9\", \"USP8\", \"BRIT1\", \"STX17\", \"GABARAP\", \"Nrdp1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}